NEW YORK, NY -- (MARKET WIRE) -- 11/03/2005 -- Amazon Biotech, Inc. (OTC BB: AMZB) today announced that it is preparing an IND for a cancer drug candidate believed to be useful in early stage breast cancer. Some of the active ingredients have shown anti-cancer efficacy in-vitro studies. The drug formulation is based upon the Amazon Biotech philosophy of several active ingredients working in combination, utilizing cutting edge whole plant pharmaceutical drug technology to create a natural, healthier pharmaceutical drug.
